Surgery vs. surgery + adjuvant chemotherapy, radiotherapy, CRT
• Rationale: may be beneficial for specific subgroups
(node-positive disease; positive margins)
• No consistent benefits
Pennathur et al, Lancet 2013
EBRO
2017